Table 2. Meta-analysis results for the effect of TB treatment on virologic suppression after combination antiretroviral therapy initiation, by length of follow-up time.
| Length of follow-up time | 1-4 months | 6 months | 11-12 months | 18-48 months | 1-48 months |
|---|---|---|---|---|---|
| No. of estimates | 3 | 8 | 7 | 5 | 13 |
| Homogeneity p-value | 0.088 | 0.064 | 0.134 | 0.718 | 0.060 |
| Estimate of between-study variance (τ2) | 0.019 | 0.008 | 0.002 | 0.000 | 0.003 |
| RRRE (95% CI) | 1.06 (0.86, 1.29) | 0.91 (0.83, 1.00) | 0.99 (0.94, 1.05) | 0.99 (0.77, 1.28) | 0.97 (0.92, 1.03) |
| 95% population effects interval | (0.81, 1.38) | (0.76, 1.09) | (0.91, 1.08) | Undefineda | (0.87, 1.08) |
| Opposite effects proportion | 34.9% | 14.9% | 41.1% | Undefineda | 29.6% |
| 95% prediction interval | (0.70, 1.58) | (0.73, 1.14) | (0.88, 1.12) | (0.74, 1.33) | (0.84, 1.12) |
Abbreviations: CI, confidence interval; RRre, random-effects summary relative risk; TB, tuberculosis
a
Undefined because τ2 = 0.000